22.03.2023

An article entitled “C-reactive Protein Apheresis in Acute Myocardial Infarction” was published in the journal Current Pharmaceutical Design, April 2023 issue, and addresses the topic of C-reactive protein apheresis (CRP-A) therapy in patients with acute myocardial infarction.

The article discusses the role of CRP in causing inflammation in the body, particularly related to cardiovascular disease. It is argued that CRP apheresis could be a promising procedure for removing CRP from the blood of acute myocardial infarction patients since high CRP levels are a risk factor for heart disease.

The commentary summarizes that the results of the ongoing randomized, multi-center clinical trial are expected to shed further light on the clinical implications of selective CRP apheresis.

You can find the full title here.